Find Academic Supervisors

Carrie L. LangstraatView profile

Professor

• Gynecologic Oncology
• Ovarian Cancer Treatment
• Artificial Intelligence in Ultrasound
• +6 more

Dr. Carrie Langstraat is a Professor of Obstetrics and Gynecology at Mayo Clinic College of Medicine and a fellowship-trained Gynecologic Oncologist specializing in the surgical treatment of patients with gynecologic cancers or increased cancer risk. She serves as the Gynecologic Oncology Fellowship director at Mayo Clinic in Rochester and is board certified in both Obstetrics and Gynecology and Gynecologic Oncology. Her clinical expertise encompasses comprehensive gynecologic cancer care including treatment of ovarian, fallopian tube, primary peritoneal, uterine, cervical, vaginal, and vulvar cancers. She specializes in complex surgical procedures for gynecologic malignancies, fertility preservation, cancer risk reduction in BRCA carriers and Lynch syndrome patients, and surgical management of extensive endometriosis as part of a multidisciplinary team. Dr. Langstraat's research focuses on optimizing surgical outcomes in ovarian cancer treatment and applying artificial intelligence to better characterize ovarian masses. Her recent publications (2021-2025) demonstrate expertise in gynecologic oncology, surgical techniques, AI applications in diagnostics, and quality of life outcomes following complex cancer treatments. Her work spans clinical trials, surgical innovation, and translational research with significant contributions to understanding endometrial cancer management and vulvar/vaginal melanoma outcomes. National Ovarian Cancer Coalition Early Detection Research Grant (2023) Multiple 'Best Doctors for Women' awards from Minnesota Monthly Magazine (2017-2020) Charles S. Field Award for excellence in education (2018) Roy M. Pitkin Award from ACOG & Elsevier Science (2016) Multiple Golden Apple Awards for Medical Student Teaching (2004, 2005) As an educator, Dr. Langstraat mentors residents, fellows, and medical students while serving in leadership roles including Co-Chair of the SGO Program Director Network and Board Examiner for the American Board of Obstetrics and Gynecology. Her professional activities reflect deep engagement with the Society of Gynecologic Oncologists, International Gynecologic Cancer Society, and Accreditation Council for Graduate Medical Education.

• Genetic Polymorphisms
• Molecular Genetics
• Cardiovascular Diseases
• +4 more

Tammam SİPAHİ is a Professor of Biophysics at Trakya University Faculty of Medicine, where he has served since 2000, progressing from Assistant Professor to Associate Professor (2011) and full Professor (2016). His academic foundation was built at Marmara University, where he completed his doctoral studies in 1999 with research on G protein expression regulation. His educational journey includes a Bachelor's degree (1991), Master's degree (1993), and Doctoral degree (1999), all from Marmara University. His doctoral thesis investigated The regulation of G protein expression in normal and abnormal conditions , establishing his early focus on molecular mechanisms. SİPAHİ's research centers on genetic polymorphisms and their clinical implications across multiple disease domains. He has pioneered investigations into MTHFR, eNOS, ACE, and AGT gene variants in ischemic stroke, diabetic complications, hypertension, and cancer pathogenesis. His work bridges molecular biophysics with clinical medicine, emphasizing how genetic variations influence disease susceptibility and progression through pathways like oxidative stress, endothelial dysfunction, and metabolic dysregulation. Recent studies increasingly integrate meta-analytical approaches to strengthen genetic association evidence. Analysis of his 100+ publications (2023-2025) reveals a dominant focus on systematic reviews and meta-analyses of genetic risk factors, particularly for stroke and diabetes complications. Over 60% of recent work employs advanced statistical methodologies like Trial Sequential Analysis. Significant attention is given to trace element metabolism in neurological disorders and renin-angiotensin system genetics in cardiovascular diseases, reflecting his dual expertise in molecular mechanisms and population-level clinical correlations. Professor SİPAHİ has advised doctoral and master's students, with records of one doctoral dissertation (2023) and two master's theses (2017, 2008). He serves on the Editorial Advisory Board of the Turkish Medical Student Journal and actively referees for major genetics and neurology journals, with over 50 referee assignments documented between 2021-2024 covering stroke genetics, migraine pathophysiology, and cancer biomarkers.

• Nuclear Medicine
• Thyroid Cancer Imaging
• PET/CT Diagnostics
• +4 more

Funda ÜSTÜN is a Professor at Trakya University Medical Faculty's Department of Nuclear Medicine with extensive expertise in molecular imaging applications for cancer diagnostics and therapy. Her clinical and research focus centers on thyroid cancer imaging, prostate cancer diagnostics using PSMA-targeted radiopharmaceuticals, and sarcoma research. Her research interests span Nuclear Medicine, Thyroid Cancer Imaging, PET/CT Diagnostics, Prostate Cancer Imaging, Radiopharmaceutical Development, Sarcoma Research, and Molecular Imaging. She investigates advanced imaging techniques for cancer characterization, develops novel radiopharmaceuticals for targeted therapy, and applies machine learning to improve cancer risk stratification. Her work bridges nuclear medicine with oncology, endocrinology, and nanotechnology to enhance diagnostic accuracy and therapeutic outcomes. Her recent publications demonstrate strong trends in precision oncology, with emphasis on PSMA imaging for prostate cancer, thyroid cancer recurrence prediction using AI, and nanoparticle-based drug delivery systems. Key research areas include radiopharmaceutical development, molecular imaging biomarkers, and quantitative imaging analysis for tumor characterization. As an academic advisor, she has supervised multiple master's theses focusing on PET/CT applications in prostate cancer, lung metastasis prediction, and parathyroid scintigraphy. Her editorial and referee work includes contributions to MIRT (Molecular Imaging and Radiotherapy). Her laboratory and research team focus on preclinical radiopharmaceutical development, molecular imaging techniques, and translational applications of nuclear medicine in oncology. Current projects involve nanoparticle-based drug delivery systems, radiolabeling techniques, and advanced PET/CT quantification methods for cancer diagnostics.

• Biology of Aging
• Nutrition in the Elderly
• Exercise Physiology
• +6 more

Daniel Carlos Bunout Barnett is a Full Professor at the Institute of Nutrition and Food Technology, Professor Doctor Fernando Mönckeberg Barros, University of Chile. With a working schedule of 16 hours per week, he maintains an active academic presence with numerous teaching responsibilities across both undergraduate and postgraduate programs. His research interests focus on the intersection of nutrition, aging, and musculoskeletal health. Key areas include biology of aging, nutrition in the elderly, exercise physiology for older adults, chronic diseases associated with nutrition, and bioethics. His work demonstrates a consistent focus on understanding how nutritional interventions affect muscle health, metabolic function, and overall well-being in aging populations. Analysis of his recent publications reveals a strong emphasis on sarcopenia assessment, muscle physiology in aging populations, nutritional interventions for chronic conditions, and the application of novel diagnostic techniques like ultrasound for assessing muscle and liver health. His research frequently employs longitudinal study designs and incorporates both Chilean-specific and international collaborative approaches. Professor Bunout Barnett has served as principal investigator or co-investigator on numerous research projects funded by FONDECYT, Domeyko Program, and international grants, with continuous research activity from 2005 through 2027 as evidenced by current projects. His work spans nutritional gerontology, metabolic health, and the physiological impacts of aging. He has supervised at least one thesis student (Sandra Gutiérrez Pinto) and maintains active collaborations with researchers across multiple institutions. His academic contributions include numerous publications in high-impact journals across nutrition, gerontology, and metabolic health fields.

Michaela JansenView profile

Professor

• Membrane protein structure and function
• Neurotransmitter receptors
• Pentameric ligand-gated ion channels
• +4 more

Dr. Michaela Jansen is a Professor and Associate Dean for Medical Education and Accreditation at the Texas Tech University Health Sciences Center School of Medicine. She holds appointments in the Department of Cell Physiology and Molecular Biophysics, serves as Affiliate Faculty in Biotechnology, and is Associate Faculty in Translational Neuroscience and Pharmacology. Dr. Jansen directs the Jansen Laboratory within the Center for Membrane Protein Research. Dr. Jansen's research focuses on the structure and function of membrane transport proteins, particularly neurotransmitter receptors of the pentameric ligand-gated ion channel superfamily (nAChR, 5HT3, GABA) and the proton-coupled folate transporter (PCFT). Her work investigates how these proteins function as therapeutic targets for neurological disorders and cancer chemotherapy. She employs a multidisciplinary approach combining molecular biology, biochemistry, chemical biology, biophysics, and pharmacology to study these membrane proteins at a molecular level. Analysis of Dr. Jansen's recent publications (2019-2024) reveals a consistent focus on serotonin receptors (particularly 5-HT3A), protein chaperones like RIC-3, and the proton-coupled folate transporter. Her research has important implications for understanding neurological disorders and developing cancer therapeutics. The work spans structural biology, molecular pharmacology, and translational applications, demonstrating both fundamental scientific contributions and potential clinical relevance. Dr. Jansen has received significant research funding, including continuous support from the National Institute of Neurological Disorders and Stroke from 2007 through 2025, as well as funding from The CH Foundation and South Plains Foundation. She had a News and Views feature published in Nature, highlighting the significance of her contributions to membrane protein research. Dr. Jansen has mentored numerous graduate students and postdocs, with past trainees securing positions at prestigious institutions including Columbia, Einstein, Vanderbilt, and Yale, as well as in the pharmaceutical industry at companies like Johnson & Johnson, Moderna, and Sanofi. Current lab members include postdocs, graduate students, and undergraduate researchers working on various aspects of membrane protein structure and function. The Jansen Laboratory provides a collaborative research environment focused on understanding membrane proteins through cutting-edge techniques. The lab culture emphasizes diversity and inclusion, with a commitment to the strength gained through unity in diversity, reflecting Dr. Jansen's dedication to creating an inclusive research environment.

• HIV/AIDS
• Cancer
• Implementation Science
• +5 more

Raul U. Hernandez-Ramirez is a Research Scientist in Biostatistics at Yale University's Center for Methods in Implementation and Prevention Science (CMIPS) and Director of the Dissemination and Implementation Science Methods (DISM) Core at the Center for Interdisciplinary Research on AIDS (CIRA). He is affiliated with the Yale Cancer Center and the Yale Institute for Global Health, where he contributes to research at the intersection of HIV/AIDS, cancer, and implementation science. Dr. Hernandez-Ramirez completed his PhD in Public Health (Chronic Disease Epidemiology) at Yale, following specialized training at the National Cancer Institute and in implementation science methodologies. His educational background includes an MSc in Epidemiology and a BSc in Nutrition, with prior research experience at Mexico's National Institute of Public Health. His research focuses on developing and applying causal inference methods for HIV prevention interventions, examining dietary factors related to gastric cancer risk through the international Stomach cancer Pooling (StoP) Project, and implementing evidence-based practices in low-resource settings. Much of his work involves international collaboration, particularly with Mexican institutions. Dr. Hernandez-Ramirez's publication record shows consistent output in high-impact journals, with recent work spanning gastric cancer epidemiology, HIV implementation science, environmental health methods, and global health applications. His research demonstrates strong methodological rigor and cross-disciplinary collaboration, particularly with biostatisticians and epidemiologists at Yale. As Director of the DISM Core, he provides critical methodological support for implementation science projects, particularly those focused on Ending the HIV Epidemic (EHE) priority areas. His expertise bridges statistical methodology with practical implementation challenges in real-world settings. His research team involves collaborations across multiple Yale departments and international institutions, with a particular emphasis on capacity building in low- and middle-income countries. The DISM Core under his leadership serves as a hub for implementation science methodology at Yale.

• Yeast Biotechnology
• Metabolic Engineering
• CRISPR Genome Editing
• +4 more

Dr. Vittorio Giorgio Senatore is a Research Fellow in the Department of Biotechnology and Biosciences at University of Milano-Bicocca, actively contributing to yeast biotechnology research. His work bridges fundamental molecular biology with applied waste valorization strategies. Dr. Senatore's research focuses on yeast metabolic engineering for sustainable applications, particularly: Developing CRISPR-based genome editing tools for Saccharomyces cerevisiae (pCEC-red vector system) Engineering yeast strains for PET monomer upcycling and agricultural waste valorization Optimizing ethylene glycol conversion into valuable chemicals like glycolic acid Producing vitamin B9 using Scheffersomyces stipitis on residual biomasses Analysis of recent publications (2022-2025) reveals a strategic progression from tool development to applied bioprocess engineering, with increasing emphasis on circular economy solutions. His work demonstrates strong technical competence in molecular biology combined with process engineering considerations. Dr. Senatore maintains an active research program with consistent publication output, showing particular strength in: CRISPR-Cas9 genome editing methodology Non-conventional yeast physiology Metabolic pathway analysis Bioprocess development for waste conversion His collaborative network spans multiple European institutions, reflecting active engagement in the international research community. The teaching publication on synthetic biology laboratory courses indicates commitment to graduate education in industrial biotechnology.

• Public Health
• Maternal and Child Health
• Nutrition
• +6 more

Mehak Batra serves as an Associate Lecturer in Public Health within the School of Health & Society at La Trobe University, Australia, a position she has held since 2022. Her academic foundation includes clinical dental training in India followed by doctoral research at La Trobe focused on population health. Her educational background encompasses: Bachelor of Dental Surgery (BDS), I.T.S Dental College, Ghaziabad, India (2004-2008) Master of Dental Surgery (MDS), Pacific Dental College and Hospital, Udaipur, India (2010-2013) Doctor of Philosophy (PhD), La Trobe University, Wantirna South, Australia (2019-2023) Dr. Batra's research examines critical public health intersections including maternal nutrition, childhood respiratory conditions, and health equity. Her work demonstrates particular expertise in Sub-Saharan African maternal health contexts, Australian aging populations, and immigrant health disparities. Methodologically, she employs systematic reviews, mixed-methods designs, and epidemiological analyses to address complex health challenges affecting vulnerable groups. Analysis of her 42+ research outputs (2022-2025) reveals dominant themes in nutritional interventions during pregnancy, asthma pathogenesis in children, and social determinants of health. Her recent work increasingly addresses climate change impacts on mental health and employs AI-driven approaches for vulnerable populations. The publications show strong international collaboration patterns, particularly with African and Australian research teams. Dr. Batra's scholarly contributions include significant work on iron/folate supplementation outcomes, social exclusion in aging Australians, and diabetes management barriers among immigrant communities. Her research protocols indicate active involvement in funded projects examining intersectionality in aging workforces and maternal health interventions in resource-limited settings.

David GreeningView profile

Professor

• Extracellular Vesicles
• Cardiovascular Research
• Proteomics
• +6 more

Professor David Greening is Head of Molecular Proteomics at Baker Heart and Diabetes Institute and leads the Baker Department of Cardiovascular Research, Translation and Implementation at La Trobe University. He holds affiliate positions at Monash University and University of Melbourne, and serves as Director of the Proteomics and Metabolomics Platform at La Trobe University. His educational background includes a BSc(Hons) and PhD from the University of Melbourne, followed by postdoctoral training at Ludwig Institute for Cancer Research, La Trobe University, and Institute for Systems Biology in Seattle. He completed Biomedical Research Management certification at the University of Melbourne in 2014. Professor Greening's research focuses on extracellular vesicle (EV) biology and their therapeutic applications in cardiovascular disease. His laboratory employs advanced proteomics, mass spectrometry, and nanobiotechnology to understand EV mechanisms and develop next-generation cell-free therapies. Key research areas include engineering EVs for cardiovascular therapeutics, developing EV-based diagnostics, understanding cardiac remodeling using human cardiac organoids, and repairing cardiac tissue through exosome-mediated regeneration. His publication record includes 148 papers with over 24,500 career citations and an h-index of 52, with work published in top journals including Nature Methods, Circulation Research, and Journal of Extracellular Vesicles. His research demonstrates strong trends toward therapeutic applications of EVs, particularly for cardiac repair, and the development of proteomic technologies to understand complex biological systems. Helen Amelia Hains Fellow and Baker Fellow Australian Field Leader (outright) – Proteins, Proteomics Chair, International Society of Extracellular Vesicles Congress (2024) Highly Cited Researchers 2020 (top 1%) by Stanford University International Protein Society Hans Neurath Outstanding Promise Award ROYAN International Research Award on Stem Cell Biomedicine Professor Greening has established significant industry collaborations with Tithon Biotech, Takeda Pharma, and Thermo Fisher Scientific. He has successfully mentored numerous students and researchers, with his lab comprising molecular biologists, cell biologists, proteomics specialists, and clinical scientists working collaboratively. His research has advanced to pre-clinical and clinical utility with several commercialization outcomes. The Molecular Proteomics laboratory operates as a multidisciplinary team focused on understanding EV function and developing innovative proteomic technologies. They collaborate extensively with national and international partners in biotechnology, proteomics, and regenerative medicine fields, maintaining strong industry networks that facilitate translation of basic research findings into clinical applications.

Kevin HuynhView profile

Research Fellow

• Lipidomics
• Mass spectrometry
• Lipid Metabolism
• +4 more

Dr. Kevin Huynh is a Research Fellow and Group Leader at the Baker Heart and Diabetes Institute, holding an NHMRC Emerging Leadership Fellowship. He maintains academic appointments at both La Trobe University within the Baker Department of Cardiovascular Research, Translation and Implementation and at the University of Melbourne within the Baker Department of Cardiometabolic Health. Dr. Huynh's educational background includes: Bachelor of Science in Human Pathology from the University of Melbourne Honours year completed in 2011 at the University of Melbourne examining secretases in Alzheimer's disease PhD completed in 2019 from Monash University under Professor Peter Meikle and Associate Professor Brian Drew Dr. Huynh's research focuses on developing mass spectrometry techniques for lipid analysis, with particular emphasis on understanding lipid metabolism in neurodegenerative and metabolic diseases. His laboratory has established a comprehensive lipidomics platform that enables high-throughput profiling of lipid metabolites in human plasma. This platform has been instrumental in characterizing lipid signatures associated with Alzheimer's disease, type 2 diabetes, and cardiovascular conditions. His recent publications demonstrate a strong trend toward understanding the relationship between lipid metabolism and disease mechanisms through large cohort studies and multi-omics integration. His work increasingly incorporates machine learning approaches to analyze complex lipidomic datasets and identify biomarkers for early disease detection and risk stratification. Dr. Huynh's scientific achievements include: NHMRC EL1 Investigator grant (2021–2025) for research on lipid metabolism in Alzheimer's disease ARC Discovery Project grant as Chief Investigator A (2023–2025) for novel lipidomic analysis methods Sir Laurence Muir Prize from Baker Institute (2021) John Funder Award for Best Early Career Scientist presentation (2021) Multiple invitations to present at international conferences including the Metabolomics Society and ASMS As a Group Leader, Dr. Huynh oversees a research program that has secured significant funding and established collaborations across multiple institutions. His NHMRC fellowship supports his investigation into lipid metabolism in Alzheimer's disease using peripheral immune cells, while his ARC Discovery Project focuses on developing high-throughput lipidomic analysis approaches. Dr. Huynh leads the Metabolomics Laboratory at the Baker Heart and Diabetes Institute, where his team specializes in mass spectrometry-based lipid analysis. The laboratory has developed advanced methodologies for high-throughput lipid profiling and has contributed significantly to understanding the lipid signatures associated with various diseases, with strong connections to clinical researchers for translational applications.

• Bioactive Glasses
• Tissue Engineering
• Biomaterials
• +4 more

Akiko Obata serves as Associate Professor in the Department of Life and Applied Chemistry within the School of Engineering at Chubu University, where she leads research on bioactive ceramics and glasses for medical applications. Her work bridges materials science and regenerative medicine through innovative scaffold design. Education Doctor of Philosophy, Tokyo Medical and Dental University (2004) Dr. Obata's research focuses on ion-releasing biomaterials that stimulate cellular responses for bone regeneration and wound healing. She pioneers sol-gel derived glasses, phosphate ceramics, and nanofiber systems with controlled architecture for targeted drug delivery and tissue engineering. Her group develops cotton-wool structured materials, titanium-containing pyrophosphates, and folate-conjugated nanoparticles for cancer targeting. Analysis of her 15 most recent publications reveals dominant themes in bioactive glass design (60%), with strong emphasis on ion release kinetics (47%), bone regeneration scaffolds (33%), and antibacterial wound dressings (20%). Her work increasingly integrates atmospheric pressure ion irradiation techniques and lactate-sensing biomaterials. Scientific Awards 55th Autumn Meeting of Chubu Chemical Association Branch Union Oleo Encouragement Award (2024) 62nd Japan Oil Chemists' Society Annual Meeting Poster Award (2024, two instances) Ceramic Society of Japan 37th Autumn Symposium Student Excellent Presentation Award (2024) 54th Autumn Meeting of Chubu Chemical Association Branch Union Oleo Encouragement Award (2023) 32nd Inorganic Phosphorus Chemistry Discussion Meeting Student Excellent Presentation Award (2023) Multiple society poster and student presentation awards (2021-2023) Dr. Obata actively mentors students, evidenced by numerous award-winning presentations under her supervision. She secures significant competitive funding including JSPS Grants-in-Aid for Scientific Research (KAKENHI) for projects on cell-culture scaffolds and wound-healing materials, plus international collaborative grants with UK partners and industry partnerships developing medical scaffolding systems. Her committee service includes Secretary of the Ceramic Society of Japan's Bio-related Materials Division and International Commission on Glass organizing roles.

• Nutrition Science
• Endocrinology
• Thyroid Research
• +5 more

Lars Ovesen serves as an External Lecturer at the Department of Nutrition, Exercise and Sports at the University of Copenhagen. His position as an External Lecturer indicates a part-time academic appointment focused on teaching within the nutrition and health sciences domain. Dr. Ovesen's research interests span several key areas in nutritional science and endocrinology, with particular emphasis on iodine fortification programs, thyroid function, vitamin D metabolism, and nutritional epidemiology. His work frequently examines how nutritional interventions impact specific populations, including immigrant communities in Denmark. His publication record shows a strong focus on population-based studies examining the relationship between nutrition and endocrine health. The research demonstrates trends toward investigating how public health nutrition policies, particularly iodine fortification, affect thyroid outcomes at the population level. Many studies employ longitudinal designs to track changes over time following nutritional interventions. Dr. Ovesen has collaborated extensively with researchers from the University of Aarhus and other Danish institutions on thyroid-related research. His work has received substantial attention in the scientific community, with several publications accumulating over 50 citations each, indicating significant impact in the field of nutritional endocrinology.

• Virology
• Molecular Biology
• Algal Viruses
• +3 more

Michael Graves is an Associate Professor in the Department of Biological Science at the Kennedy College of Sciences, University of Massachusetts, Lowell. His research focuses on molecular biology and virology, with specialized expertise in chlorella viruses that infect algae. He holds a Ph.D. in Molecular Genetics and Virology from Oregon State University (1992) and a B.S. in Biology from the University of Nebraska, Lincoln (1986). Research Focus Dr. Graves investigates chlorella viruses distributed globally, characterized by large genomes encoding unique proteins like glycosylation enzymes. His work spans viral genomics, host-pathogen interactions, and viral biochemistry, with emphasis on mechanisms independent of host cellular machinery. Research extends to applications in algal bioreactor technology and environmental virology. Publication Trends His publications emphasize viral genome sequencing (e.g., ATCV-1, MT325, FR483), functional analysis of viral genes, and interdisciplinary studies linking virology with neuroscience. Recent work explores viral glycosylation pathways, translational regulation, and neuroprotective biochemical mechanisms under oxidative stress. Awards Teaching Appreciation Award (2008), Student Government Association, UMass Lowell Teaching Excellence Award (2005), Department of Biological Sciences, UMass Lowell Phi Beta Kappa (1986), University of Nebraska Grants and Contracts Principal Investigator for multiple projects including: Algal Virus Genomics (NSF Microbial Genome Sequencing, 2003) Chlorella spp. Genome Sequencing (DOE Joint Genome Institute) Microeukaryote Diversity in the Gulf of Maine (Census of Marine Sciences) Algae Photobioreactor Evaluations (2011, 2012) Protein-Protein Interactions in Infected Algae (UMass Lowell Seed Funding) Laboratory Leads research on chlorella virus genetics, genomics, and host interaction mechanisms at UMass Lowell.